M-0674

N/A

Report date: 2025/07/08 14:51:47

Base Information

Drug NameM-0674
Drug Alias NameM-0674
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonistsTumor necrosis factor receptor superfamily member 10A agonistsAnti-MUC1
TargetsTumor necrosis factor receptor superfamily member 10BTumor necrosis factor receptor superfamily member 10AMucin-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesMerck KGaA, Darmstadt, Germany
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A